Intrexon | XON - SCHULD





SCHULD Veränderung Datum
Agenus USD 35.54M 2.34M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Amgen USD 57.32B 2.72B 2026-03
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 983.69M 5.77M 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Heron Therapeutics USD 149.65M 157K 2024-09
Incyte USD 38.27M 1.16M 2026-06
Intrexon USD 0 13.82M 2024-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Ligand Pharmaceuticals USD 451.98M 486K 2026-03
MacroGenics USD 36.51M 500K 2026-03
MannKind USD 330.96M 36.48M 2026-03
Merck USD 49.12B 222M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Thermo Fisher Scientific USD 43.16B 3.78B 2026-03
Veracyte USD 39.33M 321K 2026-03
Xencor USD 175.16M 12.58M 2026-03